BackAdvanced Biomed Common Stock Overview

Advanced Biomed Common Stock Current Cash

Track Advanced Biomed Common Stock's current cash ($2.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.60M
↑ 1566.95% YoYΔ $2.45M vs prior year quarter

Peer trimmed avg / median

Loading

Advanced Biomed Common Stock Current Cash History

Loading

Advanced Biomed Common Stock vs. peers: Current Cash Comparison

Loading

Advanced Biomed Common Stock Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Advanced Biomed Common Stock (ADVB) FAQ

As of the most recent data (March 2026), ADVB shows a current cash of $2.6M. That compares with $160K in the prior-year period — up 1567.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADVB's current cash is now $2.6M (was $160K) — a 1567.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Advanced Biomed Common Stock is outperforming or lagging.

Tracking ADVB's current cash over time shows whether Advanced Biomed Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6M That compares with $160K in the prior-year period — up 1567.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Advanced Biomed Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $2.6M) with ownership activity and broader fundamentals.